|
|
|
4528 ONO PHARMACEUTICAL CO.,LTD.
|
|
| 05/08/2026 12:00 |
Fiscal Year 2025 (April 1, 2025 to March 31, 2026) Supplementary Materials (Consolidated IFRS) |
| 05/08/2026 12:00 |
Consolidated Financial Results for the Fiscal Year Ended March 31, 2026 (IFRS) |
| 03/05/2026 12:00 |
Notice concerning Disposal of Treasury Shares by Third-Party Allotment |
| 03/05/2026 12:00 |
Notice concerning Introduction of Long-Term Incentive Stock Plan for Employees of Deciphera, the U.S. Subsidiary |
| 03/02/2026 13:05 |
Announcement on Changes of the Board of Directors and Corporate Officers |
| 02/27/2026 16:00 |
Announcement concerning the Transfer of Distribution Sales and Termination of Co-promotion for SGLT2 Inhibitor Forxiga 5 mg 10 mg in Japan |
| 02/02/2026 12:00 |
Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2026 (IFRS) |
| 10/30/2025 12:00 |
2nd Quarter of Fiscal Year 2025 (Ending March 31, 2026) (April 1, 2025 to September 30, 2025) Supplementary Materials (Consolidated IFRS) |
| 10/30/2025 12:00 |
Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2026 (IFRS) |
| 10/03/2025 16:00 |
Corporate Governance Report |
| 08/01/2025 12:00 |
Notice concerning the Establishment of Ono Global Reinsurance, Inc. as an Overseas Subsidiary (Specified Subsidiary) |
| 08/01/2025 12:00 |
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2026 (IFRS) |
| 07/18/2025 12:00 |
Notice on Completion of Disposal of Treasury Shares as Tenure-based Restricted Stock Compensation and Performance-linked Restricted Stock Compensation |
| 07/04/2025 17:00 |
[Delayed]Corporate Governance Report |
| 06/19/2025 16:30 |
Notice of Disposal of Treasury Shares as Tenure-based Restricted Stock Compensation and Performance-linked Restricted Stock Compensation |
| 05/22/2025 08:00 |
Notice of Convocation Annual General Meeting 2025 |
|
